| Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal … G Gaziev, K Wadhwa, T Barrett, BC Koo, FA Gallagher, E Serrao, J Frey, ... BJU international 117 (1), 80-86, 2016 | 214 | 2016 |
| Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics. TH Kuru, K Wadhwa, RTM Chang, LMC Echeverria, M Roethke, A Polson, ... BJU international 112 (5), 2013 | 189 | 2013 |
| Beliefs about penis size: Validation of a scale for men ashamed about their penis size D Veale, E Eshkevari, J Read, S Miles, A Troglia, R Phillips, ... The journal of sexual medicine 11 (1), 84-92, 2014 | 113 | 2014 |
| What type of prostate cancer is systematically overlooked by multiparametric magnetic resonance imaging? An analysis from the PROMIS cohort JM Norris, LMC Echeverria, SRJ Bott, LC Brown, N Burns-Cox, ... European urology 78 (2), 163-170, 2020 | 104 | 2020 |
| Penile dysmorphic disorder: development of a screening scale D Veale, S Miles, J Read, A Troglia, L Carmona, C Fiorito, H Wells, ... Archives of Sexual Behavior 44 (8), 2311-2321, 2015 | 95 | 2015 |
| Phenomenology of men with body dysmorphic disorder concerning penis size compared to men anxious about their penis size and to men without concerns: a cohort study D Veale, S Miles, J Read, A Troglia, L Carmona, C Fiorito, H Wells, ... Body Image 13, 53-61, 2015 | 71 | 2015 |
| INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of … E Johnston, H Pye, E Bonet-Carne, E Panagiotaki, D Patel, M Galazi, ... BMC cancer 16 (1), 816, 2016 | 60 | 2016 |
| Relationship between self-discrepancy and worries about penis size in men with body dysmorphic disorder D Veale, S Miles, J Read, S Bramley, A Troglia, L Carmona, C Fiorito, ... Body Image 17, 48-56, 2016 | 37 | 2016 |
| False positive multiparametric magnetic resonance imaging phenotypes in the biopsy-naïve prostate: are they distinct from significant cancer-associated lesions? Lessons from PROMIS V Stavrinides, T Syer, Y Hu, F Giganti, A Freeman, S Karapanagiotis, ... European urology 79 (1), 20-29, 2021 | 28 | 2021 |
| Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures K Wadhwa, L Carmona-Echeveria, T Kuru, G Gaziev, E Serrao, ... Asian journal of andrology 19 (1), 62-66, 2017 | 28 | 2017 |
| Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer S Luszczak, BS Simpson, U Stopka-Farooqui, VK Sathyadevan, ... Scientific Reports 10 (1), 14380, 2020 | 20 | 2020 |
| Evaluation of PSA and PSA density in a multiparametric magnetic resonance imaging-directed diagnostic pathway for suspected prostate cancer: the INNOVATE trial H Pye, S Singh, JM Norris, LM Carmona Echeverria, V Stavrinides, A Grey, ... Cancers 13 (8), 1985, 2021 | 17 | 2021 |
| Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological features JM Norris, LM Carmona Echeverria, BS Simpson, C Allen, R Ball, ... BJU international 126 (2), 237-239, 2020 | 14 | 2020 |
| Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates J Olivier, V Stavrinides, J Kay, A Freeman, H Pye, Z Ahmed, ... The Prostate 78 (16), 1229-1237, 2018 | 12 | 2018 |
| Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out JM Norris, LM Carmona Echeverria, BS Simpson, R Ball, A Freeman, ... BJU international 127 (2), 169-170, 2021 | 10 | 2021 |
| Regional histopathology and prostate MRI positivity: a secondary analysis of the PROMIS trial V Stavrinides, JM Norris, S Karapanagiotis, F Giganti, A Grey, N Trahearn, ... Radiology 307 (1), e220762, 2022 | 8 | 2022 |
| Bone scan is of doubtful value as a first staging test in the primary presentation of prostate cancer LM Carmona Echeverria, L Drudge-Coates, CJ Wilkins, GH Muir International Scholarly Research Notices 2012 (1), 585017, 2012 | 8 | 2012 |
| Exploring the Value of BRD9 as a Biomarker, Therapeutic Target and Co-Target in Prostate Cancer N Barma, TC Stone, LM Carmona Echeverria, S Heavey Biomolecules 11 (12), 1794, 2021 | 7 | 2021 |
| A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists LM Carmona Echeverria, A Haider, A Freeman, U Stopka-Farooqui, ... Scientific Reports 10 (1), 17177, 2020 | 6 | 2020 |
| MP-05.04 Multicentre Prospective Study of the Evolve: Dual 150W Laser for Bladder Outflow Obstruction: Preliminary Results G Muir, F Gomez, B Choi, A Erol, L Carmona, C Negro Urology 78 (3), S59, 2011 | 5 | 2011 |
Hayley WhitakerVerified email at ucl.ac.uk
